Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Lauren Rusckowski Duprey

Chief Transformation Officer at Takeda Pharmaceutical Co Ltd (TAK)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 15SEC TAKTakeda Pharmaceutical Co Ltd Sell 34,535191,522 held (−15%) $18.54 $640K +6.1%
Aug 12SEC TAKTakeda Pharmaceutical Co Ltd Sell 47,586226,057 held (−17%) $17.10 $814K +15.0%